Showing 11,901 - 11,920 results of 30,618 for search '(( 69 0 decrease ) OR ( 50 ((((teer decrease) OR (mean decrease))) OR (a decrease)) ))', query time: 0.87s Refine Results
  1. 11901

    Table_5_Effectiveness and tolerability of different therapies in preventive treatment of MOG-IgG-associated disorder: A network meta-analysis.docx by Xiaofei Wang (135107)

    Published 2022
    “…AZA, MMF, OC and RTX showed a trend to decrease ARR, but those results did not reach significant differences. …”
  2. 11902

    DataSheet1_Real-World Management and Clinical Outcomes of Stroke Survivors With Atrial Fibrillation: A Population-Based Cohort in Spain.docx by Clara L. Rodríguez-Bernal (11829377)

    Published 2021
    “…Regarding temporal trends, management with OAC increased by 20%, with a decrease of 50% for APT during the study period. …”
  3. 11903

    Table_1_Initial Report of a Phase I Study of LY2510924, Idarubicin, and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia.DOCX by Prajwal Boddu (5780843)

    Published 2018
    “…Three and one complete responses were observed at dose-levels “0” and “1,” respectively; the overall response rate (ORR) was 36% (4 of 11 patients). A50% decrease in CXCR4 mean fluorescence intensity was observed in 4 of 9 patients by flow cytometry, indicating incomplete suppression of CXCR4-receptor occupancy.…”
  4. 11904

    Table_2_Effectiveness and tolerability of different therapies in preventive treatment of MOG-IgG-associated disorder: A network meta-analysis.docx by Xiaofei Wang (135107)

    Published 2022
    “…AZA, MMF, OC and RTX showed a trend to decrease ARR, but those results did not reach significant differences. …”
  5. 11905

    Table_1_Effectiveness and tolerability of different therapies in preventive treatment of MOG-IgG-associated disorder: A network meta-analysis.docx by Xiaofei Wang (135107)

    Published 2022
    “…AZA, MMF, OC and RTX showed a trend to decrease ARR, but those results did not reach significant differences. …”
  6. 11906

    Table_1_Initial Report of a Phase I Study of LY2510924, Idarubicin, and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia.DOCX by Prajwal Boddu (5780843)

    Published 2018
    “…Three and one complete responses were observed at dose-levels “0” and “1,” respectively; the overall response rate (ORR) was 36% (4 of 11 patients). A50% decrease in CXCR4 mean fluorescence intensity was observed in 4 of 9 patients by flow cytometry, indicating incomplete suppression of CXCR4-receptor occupancy.…”
  7. 11907

    Table_6_Effectiveness and tolerability of different therapies in preventive treatment of MOG-IgG-associated disorder: A network meta-analysis.xlsx by Xiaofei Wang (135107)

    Published 2022
    “…AZA, MMF, OC and RTX showed a trend to decrease ARR, but those results did not reach significant differences. …”
  8. 11908

    Table_3_Effectiveness and tolerability of different therapies in preventive treatment of MOG-IgG-associated disorder: A network meta-analysis.docx by Xiaofei Wang (135107)

    Published 2022
    “…AZA, MMF, OC and RTX showed a trend to decrease ARR, but those results did not reach significant differences. …”
  9. 11909

    Table_4_Effectiveness and tolerability of different therapies in preventive treatment of MOG-IgG-associated disorder: A network meta-analysis.docx by Xiaofei Wang (135107)

    Published 2022
    “…AZA, MMF, OC and RTX showed a trend to decrease ARR, but those results did not reach significant differences. …”
  10. 11910
  11. 11911
  12. 11912
  13. 11913
  14. 11914
  15. 11915
  16. 11916

    Image 1_Ticagrelor vs. clopidogrel in dual antiplatelet therapy after coronary artery bypass surgery: a meta-analysis.tif by Liyuan Wang (795570)

    Published 2025
    “…</p>Results<p>4 randomized controlled trials and 3 observational studies (n = 2,424) were eligible for final analysis. A + T was associated with a decreased risk of all-cause mortality (OR = 0.47, 95% CI 0.31–0.70, p < 0.001, p heterogeneity = 0.80, I<sup>2</sup> = 0%) and cardiovascular mortality (OR = 0.50, 95% CI 0.31–0.82, p = 0.006, p heterogeneity = 0.71, I<sup>2</sup> = 0%), compared with A + C group. …”
  17. 11917

    Image 2_Ticagrelor vs. clopidogrel in dual antiplatelet therapy after coronary artery bypass surgery: a meta-analysis.tif by Liyuan Wang (795570)

    Published 2025
    “…</p>Results<p>4 randomized controlled trials and 3 observational studies (n = 2,424) were eligible for final analysis. A + T was associated with a decreased risk of all-cause mortality (OR = 0.47, 95% CI 0.31–0.70, p < 0.001, p heterogeneity = 0.80, I<sup>2</sup> = 0%) and cardiovascular mortality (OR = 0.50, 95% CI 0.31–0.82, p = 0.006, p heterogeneity = 0.71, I<sup>2</sup> = 0%), compared with A + C group. …”
  18. 11918

    Table_6_Evidence of a Causal Relationship Between Vitamin D Status and Risk of Psoriasis From the UK Biobank Study.XLSX by Yan Zhang (8098)

    Published 2022
    “…Additionally, 69 independent SNPs associated with circulating 25OHD level were selected for the MR analysis, and the result suggested that genetically predicted one standard deviation (SD) increment in log-transformed 25OHD was associated with 24% decreased risk of psoriasis (OR = 0.76; 95% CI: 0.60–0.98, p = 0.020).…”
  19. 11919

    Table_4_Evidence of a Causal Relationship Between Vitamin D Status and Risk of Psoriasis From the UK Biobank Study.xlsx by Yan Zhang (8098)

    Published 2022
    “…Additionally, 69 independent SNPs associated with circulating 25OHD level were selected for the MR analysis, and the result suggested that genetically predicted one standard deviation (SD) increment in log-transformed 25OHD was associated with 24% decreased risk of psoriasis (OR = 0.76; 95% CI: 0.60–0.98, p = 0.020).…”
  20. 11920

    Image_2_Evidence of a Causal Relationship Between Vitamin D Status and Risk of Psoriasis From the UK Biobank Study.png by Yan Zhang (8098)

    Published 2022
    “…Additionally, 69 independent SNPs associated with circulating 25OHD level were selected for the MR analysis, and the result suggested that genetically predicted one standard deviation (SD) increment in log-transformed 25OHD was associated with 24% decreased risk of psoriasis (OR = 0.76; 95% CI: 0.60–0.98, p = 0.020).…”